Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1MERCK SHARP & DOHME Ltd

02 1Merck Sharp & Dohme Limited

03 1Merck Sharp & Dohme Ltd

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Several substances refer to content

Brand Name : Zerbaxa

Dosage Form : POWDER FOR CONCENTRATE FOR

Dosage Strength : 1 G / 0.5 G

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Ceftolozane Sulfate; Tazobactam

Brand Name : Zerbaxa

Dosage Form : Ceftolozano+Tazobactam 1G+0,5G 10 Units Parenteral Use

Dosage Strength : 10 bottles groun EV 1 g + 0 g

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Ceftolozane Sulfate

Brand Name : Zerbaxa

Dosage Form : Powder to concentrate to the infusion fluid, resolution

Dosage Strength : 1 g/0.5 g

Packaging : Hood glass

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank